Gemina Laboratories Ltd. (CSE:GLAB)
Canada
· Delayed Price · Currency is CAD 0.0400
0.00 (0.00%)
At close: Feb 24, 2026
Gemina Laboratories Market Cap
Gemina Laboratories has a market cap or net worth of CAD 3.06 million as of March 6, 2026. Its market cap has decreased by -92.26% in one year.
Market Cap
3.06M
Enterprise Value
3.30M
Revenue
10.88K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
Market Cap Chart
Since August 11, 2021, Gemina Laboratories's market cap has decreased from 21.35M to 3.06M, a decrease of -85.65%. That is a compound annual growth rate of -34.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 24, 2026 | 3.06M | -33.33% |
| Dec 31, 2025 | 4.59M | -92.23% |
| Dec 27, 2024 | 59.14M | 49.36% |
| Dec 29, 2023 | 39.60M | 23.55% |
| Dec 30, 2022 | 32.05M | 49.59% |
| Dec 29, 2021 | 21.43M | 0.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rakovina Therapeutics | 2.96M |
| Appili Therapeutics | 2.65M |
| ASEP Medical Holdings | 3.56M |
| MindBio Therapeutics | 3.84M |
| XORTX Therapeutics | 4.18M |
| Algernon Health | 2.17M |
| BioVaxys Technology | 4.41M |
| MYND Life Sciences | 5.22M |